One (1) Automated Dry Heat Flow Through System with 8 Diffusion cells
Closed Solicitation Posted
- Solicitation number
- 75F40125Q00397
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Silver Spring, Maryland 20993, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration's Office of Pharmaceutical Quality (OPQ/OPQR) is seeking to procure one Automated Dry Heat Flow Through System with 8 Diffusion cells to support in vitro diffusion studies for evaluating drug release and permeation across synthetic and biological barriers. This specialized laboratory equipment will be used to assess the safety, performance, and quality of transdermal and drug products in support of CDER's mission-critical operations. The technical specifications require an eight-cell system with temperature-controlled chambers, automated sample collection capabilities, precise flow rate controls, and dry heat temperature control functionality. The government will evaluate quotations using a Lowest Price Technically Acceptable (LPTA) approach, with technical and price factors weighted approximately equally. Vendors must submit questions by September 3, 2025, at 11:00 AM, with final quotations due September 9, 2025, at 11:00 AM.
This procurement is designated as a total small business set-aside under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees. The contract requires delivery and installation within 12-14 weeks from award date, followed by a one-year warranty period. Installation and delivery will take place at the FDA White Oak Campus in Silver Spring, Maryland. Vendors must submit their responses in two separate volumes: a technical volume limited to 20 pages excluding pricing information, and a price volume containing the completed pricing schedule. The solicitation operates under a firm-fixed-price structure, though no specific contract value or budget range has been disclosed in the available documentation.
Notice text
The U.S. Food and Drug Administration's (FDA) OPQ/OPQR is requesting the acquisition of one (1) Automated Dry Heat Flow Through System with 8 Diffusion cells (or equivalent). This Automated Dry Heat Flow Through System with 8 Diffusion cells will be used to perform in vitro diffusion studies using flow through cell assembly to check the drug release and permeation across synthetic and biological barriers. This Automated Dry Heat Flow Through System with 8 Diffusion cells and these diffusion studies will provide valuable information regarding safety, performance, and quality of transdermal and drug products and support CDER’s mission critical missions.
Files
| File | Type | Posted |
|---|---|---|
| RFQ-75F40125Q00397_130351 Final Approved.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity